The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOPM.L Regulatory News (OPM)

  • There is currently no data for OPM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

25 Jun 2019 07:00

RNS Number : 2634D
1PM PLC
25 June 2019
 

25 June 2019

 

 

 

 

1pm plc

(the "Group" or the "Company")

 

Trading update

 

Further year-on-year growth in revenue and profit.

Planned investment to support next phase of growth.

 

 

Unaudited results:

 

1pm plc, the AIM listed specialist finance provider to the SME sector is pleased to announce the following trading update ahead of the publication of its final audited results for the financial year ended 31 May 2019, which are scheduled to be announced on 24th September 2019.

 

The unaudited trading results for the year demonstrate further growth with revenue up 6% and profit before tax, exceptional items and share based payments ("PBTE") up 4% compared with the prior year.

 

Financial highlights*

 

· Deal origination of approximately £161 million, an organic increase of over 12%

· Revenue for the year expected to be £31.8 million, an organic increase of 6%

· PBTE for the year expected to be approximately £8.2 million, an organic increase of 4%

· Fully diluted earnings per share of approximately 6.6 pence following share issues to satisfy acquisition earn-out targets being achieved, compared with 6.5 pence in the prior year, an increase of 2%

· Net Assets in excess of £53 million, an increase of more than 10% over the prior year

· A similar level of net portfolio write-offs to the prior year at approximately 1% of the net lending portfolio, but provisions prudently increased to approximately 1.9%, up from 1.5% in the prior year

· Over 50% of revenue for the current year to 31 May 2020 already secured as "unearned income" providing a good degree of visibility on future earnings

· Aggregate borrowing facilities as at 31 May 2019 were £167 million, an increase of 2% over the prior year with the blended cost of borrowing maintained at approximately 4%

· Net interest margin maintained at approximately 12%

· Maiden interim dividend paid in accordance with stated progressive dividend policy

*unaudited

 

Operational highlights

 

· 35% of deal origination was funded on balance sheet and 65% was brokered-on compared with 44% and 56% respectively in the prior year.

· The lending portfolio as at 31 May 2019, stated gross of unearned interest income, is expected to be approximately £134 million, compared with £142 million in the prior year, the decrease reflecting the increased proportion of origination brokered-on for commission income

· Substantial investment in senior management positions, including leadership of each of the Group's product divisions and core group functions

· Significant progress in marketing, branding and IT systems enhancements

· Synergies being delivered from the simplification of operations and policies in the Asset Finance division, which will deliver market-facing and processing improvements.

 

Our strategy of being a multi-product provider, allied to the flexibility of either own-book funding or broking on, has created a strong and diversified platform from which to grow. In the period reported this strategic and market positioning has enabled the Group to generate robust levels of demand whilst being able to maintain margin, control credit and spread risk.

 

Outlook

 

In January 2019, strategic and operating plans were announced for the next phase of the Group's growth through to the financial year ended 31 May 2024 including adding scale through both organic growth and carefully selected acquisitions in order to build a lending portfolio of approximately £350m. In line with these stated intentions, the Board has agreed to make further investments in sales and new business personnel, to simplify its Asset Finance operations and to rationalize the various businesses in the Group into a single, nationally recognized, brand. The Group will also continue the upgrading of its IT and communications systems to deliver online offerings, improve processing times and make its infrastructure more robust, enabling it to deliver future growth.

 

These actions will result in certain additional costs being incurred in the year ending 31 May 2020 some of which are non-recurring. The Group's sound funding position enables these actions to be taken and will support the investment required to deliver the growth plan. The Board is mindful of the continuing macro political and economic uncertainty and, therefore, taking these internal and external factors together, expects the financial year ending 31 May 2020 to be one of investment and consolidation with future benefits being derived from these actions in ensuing years.

 

Ian Smith, Chief Executive Officer, commented:

 

"In current uncertain business conditions, we are delighted to be reporting year-on-year growth in revenue and underlying profits. The unaudited results for the year ending 31 May 2019 demonstrate the strength of our market position, our multi-product offering and operating model. We are determined to deliver our planned further strategic growth in order to increase shareholder value over the next five years and now is the time to lay the foundations for that further growth."

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

 

 

For further information, please contact:

 

 

 

1pm plc

 

Ian Smith, Chief Executive Officer

01225 474230

James Roberts, Chief Financial Officer

01225 474230

 

 

Cenkos (NOMAD)

 

Max Hartley, Julian Morse (Sales)

0207 397 8900

 

 

Walbrook PR

0207 933 8780

Paul Vann/Tom Cooper

07768 807631

 

paul.vann@walbrookpr.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUSRRRKUANUUR
Date   Source Headline
7th Dec 20207:00 amRNSChange of Name to Time Finance plc
26th Nov 20207:00 amRNSDirector Share Purchases
9th Nov 20207:08 amRNSHolding(s) in Company
29th Oct 20207:00 amRNSNew Share Option Scheme
28th Oct 20207:00 amRNS1pm receives increased CBILS Lending Allocation
22nd Oct 202010:17 amRNSResult of AGM
22nd Oct 20207:00 amRNSAGM Statement & Notice of Interim Results
8th Oct 20204:13 pmRNSNotice of AGM & Voting Arrangements
8th Oct 20202:00 pmRNSHolding in Company
22nd Sep 20207:00 amRNS2020 Final Results
16th Sep 20207:00 amRNS2020 Final Results: Investor Presentation
23rd Jun 20207:00 amRNSTrading & Funding Update
5th Jun 20207:00 amRNSIssue of Equity & Notice of Results and AGM
18th May 20204:09 pmRNSHolding in Company
7th May 20207:00 amRNSInvitation to Investor Presentation
5th May 20207:00 amRNSCBILS Accreditation & Covid-19 Trading Update
28th Apr 20202:00 pmRNSDirectorate Change
27th Mar 202012:11 pmRNSInterim Dividend Update
26th Mar 20202:15 pmRNSCovid-19 Update
19th Feb 20207:00 amRNSIncreased Funding Facility with NatWest
15th Jan 20207:00 amRNSInterim Results
26th Nov 20197:00 amRNSIncreased and Improved Funding Facilities
8th Nov 20192:57 pmRNSDirector/PDMR Shareholding
8th Nov 201911:34 amRNSHoldings in Company
6th Nov 201911:09 amRNSResult of AGM and GM
21st Oct 20197:00 amRNSNotice of General Meeting
18th Oct 20195:27 pmRNSDirector/PDMR Shareholding
15th Oct 20191:04 pmRNSDirector/PDMR Shareholding
11th Oct 201912:00 pmRNSHoldings in Company
25th Sep 20197:00 amRNS2019 Final Results
3rd Sep 20197:00 amRNSIssue of Equity, Key Dates and Proposed Dividend
17th Jul 201910:00 amRNSHolding(s) in Company
25th Jun 20197:00 amRNSTrading Update
18th Jun 20197:00 amRNSPositive Cashflow achieves earn-out a year early
5th Jun 20197:00 amRNSSenior Management Appointment
20th Mar 20193:29 pmRNSDirector/PDMR Shareholding
14th Mar 20197:00 amRNSSenior Management Appointments
5th Mar 20197:00 amRNSInvoice finance facilities extended with Natwest
13th Feb 20194:57 pmRNSChange in significant shareholding
16th Jan 20194:27 pmRNSDividend Timetable Update
16th Jan 20199:51 amEQSHardman & Co Research: 1pm Plc (OPM): Interim results 1H FY'19: geared up for growth
16th Jan 20197:00 amRNS2019 Interim Results
4th Dec 20187:00 amRNSTrading & Dividend Update; Date of Interim Results
21st Nov 20187:00 amRNSLeasing Life Award
1st Nov 201812:46 pmRNSTotal Voting Rights
25th Oct 20184:05 pmRNSResult of AGM
25th Oct 20187:00 amRNSAGM Statement
22nd Oct 20187:00 amRNSPositive Cashflow achieves First Year earn-out
12th Sep 20189:29 amEQSHardman & Co Research: 1pm (OPM): Group synergies coming through
12th Sep 20187:00 amRNS2018 Final Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.